Dr. Andi Flory on pioneering non-invasive pet cancer detection

Dr. Andi Flory is the Chief Medical Officer and co-founder of PetDx, a company that’s pioneering veterinary cancer diagnostics. A board-certified veterinary oncologist, Dr. Flory has dedicated her career to advancing cancer detection and treatment for pets. With a passion for improving the lives of animals and their families, she has been at the forefront of developing innovative solutions to detect cancer in its early stages, such as PetDx’s OncoK9 liquid biopsy test which uses next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms.

A board-certified veterinary oncologist, Dr. Flory’s extensive clinical background and research has made her work widely recognized for its potential to revolutionize veterinary medicine. Committed to education and collaboration, she works directly with veterinarians to integrate these advancements into everyday practice, with the goal of providing pets with more accurate diagnoses and better outcomes in their cancer care.

Learn more about Dr. Flory

PetDX closed late Spring of ’24.